PFSA Profusa, Inc Total Debt to Capital

Profusa Inc (PFSA) relies on a staff of top-tier electronics developers and engineers, successfully avoiding labor shortages. The company's strategy is based on partnerships with the defense sector and research centers to implement implants. This chart of the total debt-to-equity ratio history on GURU.Markets shows 0.00. The business generates revenue by creating automated biosensors that transmit glucose and oxygen data directly to smartphones.

Profusa - PFSA Debt to Capital (period 07/15/2025 - 10/28/2026)

Comprehensive metric breakdowns and analytics for Profusa, Inc (PFSA)

- price and consensus price forecast:
Stock Quotes Profusa|PFSA - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Profusa|PFSA - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Profusa|PFSA - Total Stockholders' Equity|Market Value to Book Value Ratio profusa.com|PFSA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Profusa Inc|PFSA - Long-Term Debt to Capital|Short-Term Debt to Equity Profusa Inc|PFSA - Company Aggregate Indebtedness|Debts to Book Capitalization Profusa|PFSA - Long-Term Debt|Company Current Liabilities Profusa
Basic company analysis:Profusa PFSA

When selecting assets with a high margin of fundamental strength, it is critical to evaluate the financing structure through the balance of debt and equity. This indicator measures the business's degree of dependence on creditors, which for Profusa Inc. (PFSA) confirms financial stability while maintaining a costly engineering staff and biosensor experts, clearly reflecting the ratio of total liabilities to equity.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Profound Medical (PROF) - Total Debt to Capital Coefficient|Total Debt to Capital BDMD|Total Debt to Equity Ratio EDAP Medical (EDAP)|Apyx Medical (APYX) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ICCM (icecure-medical.com)|Pulmonx - Debt to Equity|Total Debt to Equity Ratio TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Debt to Capital|SRTS - Debt to Capital|Total Debt to Capital Zynex, Inc.|electroCore (ECOR) - Debt to Equity Ratio|RBOT: Total Debt to Capital|Total Debt to Capital Coefficient Inspira Technologies Oxy B.H.N. Ltd|Total Debt to Capital ICU (SeaStar Medical Holding Corp)|Total Debt to Equity Ratio iridex.com (IRIX)|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Total Debt to Capital|SSKN - Debt to Equity|glucotrack.com (GCTK) - Debt to Equity|Total Debt to Equity Ratio NanoVibronix NAOV|Venus Concept Corporation (VERO) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital NUWE (Nuwellis, Inc.)|Debt to Capital AEMD|ASXC: Debt to Equity|Debt to Capital Ratio Avinger Inc. AVGR|Total Debt to Equity Ratio BSGM (BioSig Technologies, Inc.)|Total Debt to Capital Cutera Inc CUTR|Total Debt to Capital KNW (Know Labs, Inc.)|NARI: Total Debt to Capital Coefficient|Debt to Equity Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Aggregate Debt to Equity|Debt to Equity SILK